Encube acquired soframycin from Sanofi, entering the branded topical space. 

This marked the start of strategic transformation Journey

Retail visibility boosted via channel promotion across key chemist outlets ensured product continuity during brand transition

Encube launched its own field team for stronger market coverage. Focused on doctor engagement and retail penetration

Fresh, modern packaging rolled out with 4- dots enhanced brand appeal while preserving legacy identity

OTC pilot launched to test consumder traction in Maharashtra. Insights gathered for future direct to consumer expansion

New Sophramycin variant (Powder & spray). Introduced nationally, backed by  high decibel all India media campaign